List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Telemedicine Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 114 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 114 pages
- Published: 07-06-2019
Market Overview
The global telemedicine market was valued at USD 38,046 million in 2018, and it is estimated to be valued at USD 103,897.77 million in 2024, witnessing a CAGR of 18.23%. Certain factors that are driving the market growth include increasing medicare reimbursement for telehealth services, increasing prevalence of chronic diseases, and technological innovation in communication technology across the world
Medicine these days is increasingly dependent on technology. The use of technology to transfer large amounts of digital information effortlessly at a relatively low cost is possible through telemedicine. With telemedicine, healthcare experts can listen to a patient’s heart remotely, look at and operate an electrocardiogram (ECG), X-rays, computed tomography (CT) scans, and other imaging data, obtained from several hundred miles away.
Many innovative strategies have provided consumers with insights into their own health. Recent advancements in the use of sensor technology and data capture have created opportunities for patients to conduct their own home-health check. The equipment to support telemedicine can be accessed using everyday technology, such as tablets, mobiles, and laptops. Hence, these technological innovations are driving the telemedicine market.
Scope of the Report
As per the scope of the report, telemedicine services and systems have made the most progress in remote management of post-acute care patients with chronic conditions. Telemedicine is the remote delivery of healthcare services, such as consultations over the telecommunication or teleconference, which allows healthcare professionals to evaluate, diagnose, and treat patients.
Key Market Trends
On-premise Delivery is Expected to Dominate the Telemedicine Market
The on-premise delivery segment of the telemedicine market is believed to have largest market size and is expected to witness a CAGR of 16.7% during the forecast period.
Along with that, telecardiology, a sub-segment of clinical service, is expected to have the largest market size during the forecast period and is expected to register a CAGR of 18.4%. Telecardiology is gradually started to increase in emerging markets. It provides all kinds of cardiac investigations, like basic lipid profile (cholesterol levels), electrocardiogram (ECG), echocardiogram (ECHO), coronary angiogram, Holter monitor (24 Hours ambulatory ECG monitoring), stress echo, pediatric echo, treadmill testing (TMT), carotid ultrasounds, etc.
Apart from reaching to patients directly, telecardiology services are useful in improving the efficiency in cardiac units of hospitals and medical imaging practices. With the number of cardiac patients increasing every day, remote monitoring helps in cost saving, up to around 50%, including improved patient satisfaction and quality of life, when compared to traditional outpatient care.
North America is Expected to Dominate the Market
North America currently dominates the market for telemedicine and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increased adoption of telemedicine and rising demand for mobile health services. The United States holds the majority of the market in the North American region, due to the involvement of accountable care organizations (ACOs) in both medicare and privately insured services. In addition, there is a rise in per capita health expenditure in the country, which is expected to increase over the forecast period, owing to decrease in the unemployment rate.
Competitive Landscape
The telemedicine market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products with fewer prices. Companies, like Allscripts Healthcare Solutions Inc., BioTelemetry, Medtronic, and Philips, hold significant market shares in the telemedicine market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases
4.2.2 Growing Medicare Reimbursement for Telehealth Services
4.2.3 Technological Innovation in Communication Technology
4.3 Market Restraints
4.3.1 Privacy and Security Concerns in Telehealth
4.3.2 Lack of Interoperability Between eHealth Solutions
4.3.3 Inadequate or Fragmented Legal Frameworks Including the Lack of Reimbursement Schemes for eHealth Services
4.4 Industry Attractiveness of Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Telehospitals
5.1.2 Telehomes
5.1.3 mHealth (Mobile Health)
5.2 By Clinical Service
5.2.1 Teleconsultation
5.2.2 Telepathology
5.2.3 Telecardiology
5.2.4 Telesurgery
5.2.5 Teleradiology
5.2.6 Teledermatology
5.2.7 Telepsychiatry
5.2.8 Other Clinical Services
5.3 By Technology
5.3.1 Hardware
5.3.2 Software
5.3.3 Telecom
5.4 By Mode of Delivery
5.4.1 On-premise Delivery
5.4.2 Cloud-based Delivery
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 United Kingdom
5.5.2.2 Germany
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aerotel Medical Systems
6.1.2 AMD Global Telemedicine Inc.
6.1.3 BioTelemetry
6.1.4 Honeywell Life Care Solutions
6.1.5 InTouch Technologies Inc.
6.1.6 Medtronic
6.1.7 Philips
6.1.8 SHL Telemedicine Ltd
6.1.9 Allscripts Healthcare Solutions Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type
Telehospitals
Telehomes
mHealth (Mobile Health)
By Clinical Service
Teleconsultation
Telepathology
Telecardiology
Telesurgery
Teleradiology
Teledermatology
Telepsychiatry
Other Clinical Services
By Technology
Hardware
Software
Telecom
By Mode of Delivery
On-premise Delivery
Cloud-based Delivery
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Wearable Medical Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 10-06-2019
Market Overview
The growth of the global wearable medical devices market is due to the increasing technological advancements and innovations, as it can improve the lifestyle of patients, as well as the general population. Currently, these devices are gaining immense popularity, due to improved technologies that are being introduced every day by key market players.
Additionally, ease-of-use and interpretation of medical devices and increasing per-capita income in developing countries are the other important factors responsible for the growth of the market.
Less attractive reimbursement for wearable devices and lack of awareness among people are hindering the growth of the market. Additionally, the cost of wearable devices is one of the major challenges for the growth prospects of the market.
Scope of the Report
Wearable medical devices are capable of diagnosing or monitoring medical conditions, combined with digital health information, typically worn over the body. The demand for wearable medical devices and remote patient monitoring are continuously increasing in the global market, where technological advancements, innovations, and rising disposable income, along with healthcare expenditure and better healthcare management using medical devices are among the major drivers. Some of the significant barriers of growth in this market include the high cost of wearable devices that varies as per the application, reimbursement issues, and lack of awareness in low- and middle-income countries.
Key Market Trends
Remote patient monitoring is expected to exhibit the fastest growth rate over the forecast period
The rise in the number of people with chronic medical conditions and increase in geriatric population are the major factors driving the growth of remote patient monitoring (RPM) services all over the world. The RPM also called homecare telehealth, is a process in which patients can use a mobile medical device to perform a routine test and send this data to healthcare professionals in real time.
Implementation of RPM can improve the management of chronic diseases by measuring critical risk indicators, such as glucose, blood pressure, etc. RPM has various benefits for end users and hospitals, such as low cost of healthcare, reduction in extended hospitalization, and fewer doctor appointments, among others. This can also help to reduce the cost associated with the treatment of chronic diseases.
North America captured the largest market share and is expected to retain its dominance
North America dominated the overall wearable medical devices market, with the United States emerging as the major contributor to the market. The United States holds the largest share in the global wearable medical devices market, primarily attributed to the early adoption of wearable medical technology and high prevalence of cardiovascular and lifestyle-related diseases, along with high per capita medical expenditure. Apart from these factors, the presence of a large pool of mid- and large-sized device manufacturers also supplements the large market share. Favorable laws for setting up a business and robust intellectual property rights environment acted as catalysts for the growth for many wearable medical device startups, many of which are now global players.
Competitive Landscape
Rising number of market players is intensifying the competition. Players, such as Fitbit, Lifesense, Apple, Garmin, and Samsung, among others, are disrupting the market by launching several new products. The rate of technological advancements in this market is very high, and therefore, competitors are continuously investing heavily in R&D activities. Moreover, the competitor activity is very high across both the online and retail channels.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Increasing Technological Advancements and Innovations
4.3.2 Increasing Per-capita Income in Developing Countries
4.3.3 Ease-of-use and Interpretation of Medical Devices
4.4 Market Restraints
4.4.1 High Cost of Wearable Devices
4.4.2 Unfavorable Reimbursement Issues
4.4.3 Current Lack of Awareness in Some Regions
4.5 Industry Attractiveness- Porter’s Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Wearable Vital Sign Monitor
5.1.1.1 Wearable Heart Rate Monitor
5.1.1.2 Wearable Activity Monitor
5.1.1.3 Wearable Electrocardiograph
5.1.1.4 Wearable Sleep Monitor
5.1.2 Wearable Fetal Monitor and Obstetric Device
5.1.3 Neuro-monitoring Device
5.1.3.1 Electroencephalograph
5.1.3.2 Electromyograph
5.1.3.3 Pain Management Wearable Medical Device
5.1.3.4 Glucose/Insulin Monitoring Wearable Device
5.1.3.5 Respiratory Therapy Wearable Device
5.2 Application
5.2.1 Sports and Fitness
5.2.2 Remote Patient Monitoring
5.2.3 Home Healthcare
5.3 Device Type
5.3.1 Watch
5.3.2 Wristband
5.3.3 Clothing
5.3.4 Ear Wear
5.3.5 Other Device Types
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 United Kingdom
5.4.2.2 Germany
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Garmin Ltd
6.1.2 Apple Inc.
6.1.3 Fitbit
6.1.4 Lifesense
6.1.5 LifeWatch AG
6.1.6 Philips Electronics
6.1.7 Samsung
6.1.8 Sotera Wireless
6.1.9 Xiaomi Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Product Type
Wearable Vital Sign Monitor
Wearable Heart Rate Monitor
Wearable Activity Monitor
Wearable Electrocardiograph
Wearable Sleep Monitor
Wearable Fetal Monitor and Obstetric Device
Neuro-monitoring Device
Electroencephalograph
Electromyograph
Pain Management Wearable Medical Device
Glucose/Insulin Monitoring Wearable Device
Respiratory Therapy Wearable Device
Application
Sports and Fitness
Remote Patient Monitoring
Home Healthcare
Device Type
Watch
Wristband
Clothing
Ear Wear
Other Device Types
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Aesthetic Threads Market Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 117 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 117 pages
- Published: 07-06-2019
Market Overview
The growth of the global aesthetic threads market, (henceforth, referred to as the market studied) can be attributed to the increasing use of minimally invasive treatments for anti-aging, face lifting, and face rejuvenation. Another reason for the growth is the increasing preference for minimally invasive surgeries. Given the wide variety of indications that can be targeted by cosmetic threads, the potential patient pool for cosmetic threads is enormous. However, the market studied remains in its infant stage, especially in the United States. The high cost of treatment and uncertain results act as restraints for the growth of the market studied. Additionally, the global use of an aesthetic thread, as a medical device, is largely unregulated. Only few regions regulate the use of aesthetic threads during cosmetic procedures.
Scope of the Report
Aesthetic threads are medical sutures that are injected using a needle underneath the skin, to lift and rejuvenate the skin. Suspension threads are one variety of long cosmetic threads that have cones or barbs, which pull backward on sagging skin, when injected with a needle into the target area on the face. Rejuvenation threads are another variety that have less of a lifting mechanism, but stimulate natural collagen production, when injected underneath the skin.
Key Market Trends
Suspension Thread Segment is expected to Exhibit Fastest Growth Rate Over the Forecast Period
Suspension thread is a minimally invasive surgical technique for facial rejuvenation, with lower risk of complications, low procedural and recovery time, and efficiency in correcting ptosis and aging characteristics. These advantages have led many specialists to adopt suspension threads over other aesthetic surgeries. Suspension thread techniques, together with traditional rhytidectomy incisions, are generally used to achieve better facial rejuvenation results.
The Aptos subdermal suspension threads, evolved from the concept of skin and fascia, adhere to the barbed suture; thus, creating elevation. It was developed by Marlen and George Sulamanidze in Russia. Concomitantly, the barbed suture or Contour Thread, developed by Dr. Greg Ruff at Duke University and in the United States, is now FDA approved and is used as a similar unidirectional barbed suspension thread. Thus, the rising demand for anti-aging treatments and the lesser number of complications associated with suspension threads are driving the market growth for suspension threads.
North America captured the Largest Market Share and is expected to retain its Dominance
North America dominated the overall aesthetic threads Market with the United States accounting as the major contributor to the same. In early 2015, Sinclair Pharma received an FDA approval for its Silhouette Instalift suspension thread brand. The FDA has also approved the Silhouette Soft Lift (thread lift) procedure in the United States, which helps to drive the market in the country. Only a few years old, thread lift is one of the fastest-growing cosmetic procedures in the United States, and has received a lot of exposure for the past many years, which is likely to help grow the aesthetic thread market in the upcoming years. There are a wide variety of indications that cosmetic threads can target, and the potential patient pool for cosmetic threads is enormous. However, the aesthetic threads market is still to reach its full potential in North America, and is expected to grow at a robust growth rate during the forecast period.
Competitive Landscape
The market studied is highly fragmented, with the majority of manufacturing operations taking place in North American countries. The key global players in the market studied include Aptos International Ltd, Croma Pharma GmbH, Sinclair Pharma, River Aesthetics, and 1stSURGICONCEPT, among others. The industry is witnessing a series of acquisitions and mergers.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Preference for Minimally-invasive Surgeries
4.2.2 Less Time-consuming Procedures
4.3 Market Restraints
4.3.1 High Cost of Treatments
4.3.2 Uncertain Results
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Suspension Thread
5.1.2 Rejuvenating Thread
5.2 Indication Type
5.2.1 Face Lift
5.2.2 Skin Rejuvenation
5.2.3 Ptosis
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aptos International Ltd
6.1.2 Croma Pharma GmbH
6.1.3 Healux Corporation
6.1.4 Metro Korea Co. Ltd
6.1.5 Aesthetic Experts Lab
6.1.6 Sinclair Pharma
6.1.7 N-Finders Co. Ltd
6.1.8 River Aesthetics
6.1.9 1st SurgiConcept
6.1.10 Menarini Group
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Product Type
Suspension Thread
Rejuvenating Thread
Indication Type
Face Lift
Skin Rejuvenation
Ptosis
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Over the Counter Drugs Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 120 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 120 pages
- Published: 07-06-2019
Market Overview
The global over the counter drugs market was valued at USD 303.51 billion in 2018, and it is estimated to be valued at USD 491.02 billion in 2024, witnessing a CAGR of 8.5%. The growth propelling factors of this market are product innovations, high penetration in the emerging market, favorable regulatory framework, and inclination of pharmaceutical companies toward OTC drugs from Rx drugs.
The global over the counter (OTC) drugs market is likely to record the highest growth rate in the emerging markets of Latin America and Southeast Asia over the coming years. This can be attributed to the rapidly growing population, coupled with the growing middle class in these regions and increase in disposable income of the population, which will add critical mass to the population available to access OTC medication. Along with new channels of the accessibility in emerging markets in retail outlets, supermarkets are also contributing to the growth of the OTC medication market in the emerging economies.
Scope of the Report
As per the scope of this report, over the counter drugs are referred to as non-prescription drugs. These medicines can be bought by an individual without the doctor’s prescription and are safe for consumption without the doctor’s consent.
Key Market Trends
Weight-loss and Dietary Products Segment Expected to Grow with a High CAGR
The weight-loss and dietary products segment is believed to show the highest CAGR of 8.10% during the forecast period. This is majorly attributed to the rising awareness of the general population about health and rise in the consumption of junk food, which is leading to the rise in lifestyle-related diseases. The VMS (vitamins, minerals, and supplements) segment is believed to have the largest market share.
VMS and weight loss OTC drugs contribute the most to the overall market. In fact, nearly 1/4th of the market belongs to this segment. The reason for this major share is the vast customer base for various products under this category. Unlike other conditions, which are intense in nature, the VMS and weight loss conditions are not very bothersome. OTC products for these conditions are more of precautious nature than that of treatment or cure. And this is why the number of customers is relatively high than the ones for other indications. Large customer pools give rise to high demand, which, in turn, results in high revenue generation. VMS products are very popular in developed countries because of the increasing unhealthy population
North America is Expected to Dominate the Market in the Forecast Period
North America currently dominates the market for over the counter drugs and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the leading trend among pharmaceutical companies to switch from Rx to OTC drugs. Report of the National Institute of Health has stated that 93% of adults in the United States prefer to treat their minor ailments with OTC medicines before seeking professional care, and 85% of parents in the United States prefer to treat their children’s minor ailments with an OTC medicine before seeking professional care. This is resulting in the formation of the bigger market.
Competitive Landscape
The over the counter drugs market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices. Companies, like Johnson and Johnson, Novartis AG, Bayer AG, Glaxosmithkline PLC, and Pfizer, holds significant market shares in the over the counter drugs market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Product Innovation
4.2.2 High Penetration in Emerging Markets
4.2.3 Favorable Regulatory Framework
4.2.4 Inclination of Pharmaceutical Companies Toward OTC Drugs from RX Drugs
4.3 Market Restraints
4.3.1 Probability of Substance Abuse
4.3.2 Lack of Awareness in Rural Areas
4.4 Industry Attractiveness of Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Cough, Cold, and Flu Products
5.1.2 Analgesics
5.1.3 Dermatology Products
5.1.4 Gastrointestinal Products
5.1.5 Vitamins, Mineral, and Supplements (VMS)
5.1.6 Weight-loss/Dietary Products
5.1.7 Ophthalmic Products
5.1.8 Sleeping Aids
5.1.9 Other Product Types
5.2 By Distribution Channel
5.2.1 Hospital Pharmacies
5.2.2 Retail Pharmacies
5.2.3 Online Pharmacy
5.2.4 Other Distribution Channels
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 United Kingdom
5.3.2.2 Germany
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Johnson and Johnson
6.1.2 Novartis AG
6.1.3 Bayer AG
6.1.4 Sanofi
6.1.5 Pfizer
6.1.6 GlaxoSmithKline PLC
6.1.7 Perrigo Company PLC
6.1.8 Reckitt Benckiser Group PLC
6.1.9 Takeda Pharmaceutical Company Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product Type
Cough, Cold, and Flu Products
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight-loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Other Product Types
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Other Distribution Channels
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Aesthetic Fillers Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 116 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 116 pages
- Published: 07-06-2019
Market Overview
The growth of the aesthetic fillers market can be attributed to the increasing trend of using anti-aging treatments and the demand for a much younger lifestyle. The demand for the ever-expanding range of dermal fillers and the number of operations performed has boosted the growth of the market studied. Due to the growing demand for facial aesthetics, which have a high demand for a wide range of products that treat various areas and the increasing average expenditure per patient in clinics, the market studied is growing. However, the side effects associated with dermal fillers and other factors are hindering the growth of the market studied.
Scope of the Report
The scope of this report comprises of the products currently available in the market studied. These fillers are used for anti-aging factors and are also helpful in several areas of treatment, including acne scars, enhancement of the dorsal area of hand, and increasing the volume of facial areas. The scope of this report is limited to injectables used in the above-mentioned procedures.
Key Market Trends
Absorbable Aesthetic Filler Segment is expected to exhibit Fastest Growth Rate Over the Forecast Period
Wrinkles are the first visible signs of aging. A face marked by furrows appears tired and neglected. Wrinkles are like small fractures of the skin, and the the aim of a filler is to fill them. Dermal fillers, also known as injectable implants, soft tissue fillers, or wrinkle fillers, are medical device implants approved by the FDA, in order to help create a smoother and/or fuller appearance in the face, including nasolabial folds, cheeks, and lips and to increase the volume of the back of the hand.
The FDA has approved some dermal fillers for the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus (HIV). Also, several absorbable dermal fillers are approved by FDA , for lip and cheek augmentation in patients over the age of 21 and for the correction of contour deficiencies, such as wrinkles and acne scars. Any dermal filler can cause short- or long-term side effects, permanent side effects, or a combination. However, most of these side effects occur shortly after the procedure and go away in less than two weeks. Due to factors, like FDA approval to various absorbable fillers, the market for the same is expected to grow over the forecast period.
North America captured the Largest Market Share and is expected to Retain its Dominance
North America dominated the overall aesthetic filler market with the United States accounting as the major contributor to the market. Recently, consumers, around the world are showing increasing interest toward their aesthetic appearance. Aesthetic fillers that contain hyaluronic acid, collagen, and polymers and particles are used to give the skin or feature a cosmetic boost. As per the data from the American Society of Plastic Surgeons, around 2.6 million procedures have been performed in the United States using soft tissue fillers in 2016, which was 2% higher than in 2015. The increase was attributed to the safe and effective minimally-invasive procedures and their lesser side-effects. As of 2016, about 30 aesthetic fillers are approved and possess HA license for sale in Canada. Hence, the above statistics and facts affirms that the market studied is expected grow in the forecast period.
Competitive Landscape
The market studied is highly fragmented, with the majority of the manufacturing operations in North American countries. The presence of a significant number of players in the market studied has an impact on the prices of products by firms, such as Allergan, Integra Lifesciences, Galderma Pharma SA, Teoxane, and Sinclair Pharma PLC, among others. The industry is witnessing a series of acquisitions and mergers.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Facial Aesthetics
4.2.2 Rising Acceptance of Tissue Fillers with Increasing Dermal Filler Surgeries
4.2.3 Growing Aging Population
4.3 Market Restraints
4.3.1 Side Effects Associated with Dermal Fillers
4.3.2 Negative Effects of Unregistered Practitioners
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Absorbable
5.1.2 Non-absorbable
5.2 Material Type
5.2.1 Hyaluronic Acid
5.2.2 Polymers and Particles
5.2.3 Collagen
5.3 Application
5.3.1 Facial Line Correction
5.3.2 Face Lift
5.3.3 Lip Treatment
5.3.4 Other Applications
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan
6.1.2 Galderma Pharma SA
6.1.3 Integra Lifesciences
6.1.4 Laboratoires Vivacy SAS
6.1.5 Merz Pharma
6.1.6 Sinclair Pharma
6.1.7 Suneva Medical Inc.
6.1.8 Teoxane
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Product Type
Absorbable
Non-absorbable
Material Type
Hyaluronic Acid
Polymers and Particles
Collagen
Application
Facial Line Correction
Face Lift
Lip Treatment
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Contact Lenses Market – Growth, Trends, and Forecasts (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 10-06-2019
Market Overview
The growth of the global contact lens market is due to the increasing prevalence of optical disorders, increasing tendency to enhance aesthetics, and increasing disposable incomes. As of 2017, according to WHO estimates, age-related macular degeneration (AMD) ranked third among the global causes of visual impairment, with the prevalence of blindness being 8.7%. It is the primary cause of visual deficiency in industrialized countries. Additionally, an emerging important cause of visual impairment in the developed regions of the world is uncorrected refractive errors.
According to the 2010 assessment by WHO, cataract was responsible for 51% of world blindness, which represented approximately 20 million people. Due to increasing life expectancy, particularly in the developed region of the world, the number of people with cataract is anticipated to grow. Consequently, cataract is an important cause of low vision in both developed and developing countries. A higher disposable income translates to greater spending in all areas of personal expense. The increasing disposable income in the developed countries is prompting the purchase of low-priority commodities, specifically those pertaining to cosmetics. Consequently, increasing disposable income in developed countries is a driver for the growth of the global contact lens market.
Scope of the Report
Contact lenses not only serve the need to alleviate the use of hard-to-manage and bulky spectacles, but also provide the added benefit of enhancing one’s aesthetic appeal. The increasing innovations in the production of contact lenses during the past decade have led to the use of various materials for producing lenses that serve multiple purposes. Contact lenses are also used to treat common eye disorders, such as myopia, hypermetropia, presbyopia, astigmatism, and glaucoma.
Key Market Trends
Rigid Gas Permeable Contact Lenses Segment is Expected to Exhibit the Fastest Growth Rate over the Forecast Period
A rigid gas permeable lens is also known as RGP lens or GP lens. It is a rigid contact lens made of oxygen-permeable polymers. They are porous and allow the oxygen to pass through them. These rigid lenses are able to replace the natural shape of the cornea with a new refracting surface. Since their introduction, these lenses have essentially replaced non-porous polymethyl methacrylate (PMMA) contact lenses.
These lenses often provide sharper vision than soft and silicone hydrogel contacts, especially if someone has astigmatism. It usually takes some time for the eyes to adjust to these lenses, but after this initial adaptation period, most people find that these lenses are as comfortable as hydrogel lenses.
Although these lenses have dominated the market earlier, they have lost significant value in the past two decades with the advancement of soft lenses in the market. Hence, they are much more cost effective and generally last long when taken care of properly, as long as one does not require a prescription change. This may be a driving factor for the forecast period.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America holds the largest share in the global contact lenses market with the United States being the largest contributor to its revenue. The United States is one of the major countries in the contact lens market, due to the healthcare facilities available in the country and high healthcare conditions. Factors, such as the presence of geriatric population and the prevalence of eye diseases and injuries, in terms of contact lens market, are primarily fueling the growth.
The National Eye Institute has estimated that over 2.9 million US residents were detected with low vision in 2014. The number is projected to increase further and is expected to reach around 5 million by the year 2030. In addition to this, as per a report by the US Centre of Disease Control and Prevention, about 40.9 million wearers of contact lenses were aged 18 or older, accounting for about 16.7% of the adult population in the United States in 2015. This increase is anticipated to accelerate the growth of contact lenses wearers in the country over the forecast period.
Competitive Landscape
The global contact lenses market is highly competitive and consists of several major players. The presence of major market players, such as Staar Surgical, Novartis AG, Bausch Health Companies Inc., Zeiss Group, and The Cooper Companies are, in turn, increasing the overall competitive rivalry of the market. With moderate sustainable competitive advantage through innovative products and low competition between online and offline companies, moderate competitive rivalry is observed in this market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Increasing Prevalence of Optical Disorders
4.3.2 Increasing Tendency to Enhance Aesthetics
4.3.3 Increasing Disposable Incomes
4.4 Market Restraints
4.4.1 Availability of Alternative Techniques
4.4.2 Complications Associated with Lens
4.5 Industry Attractiveness Porter’s Fives Force Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Soft Contact Lenses
5.1.2 Hybrid Contact Lenses
5.1.3 Rigid Gas Permeable Contact Lenses
5.1.4 Other Product Types
5.2 By Usage
5.2.1 Corrective Contact Lenses
5.2.2 Therapeutic Contact Lenses
5.2.3 Cosmetic Contact Lenses
5.2.4 Prosthetic Contact Lenses
5.3 By Modality
5.3.1 Conventional
5.3.2 Disposable
5.3.2.1 Daily
5.3.2.2 Monthly
5.3.2.3 Other Disposable Modalities
5.4 By Design
5.4.1 Spherical
5.4.2 Toric
5.4.3 Multifocal
5.4.4 Other Designs
5.5 By Distribution Channel
5.5.1 Spectacle Stores
5.5.2 Online Store
5.5.3 Other Distribution Channels
5.6 Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 United Kingdom
5.6.2.2 Germany
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle East & Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle East & Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Staar Surgical
6.1.2 Novartis AG
6.1.3 Bausch Health Companies Inc.
6.1.4 Zeiss Group
6.1.5 The Cooper Companies
6.1.6 Essilor International SA
6.1.7 Hoya Corporation
6.1.8 Haohai Biological Technology
6.1.9 Johnson & Johnson Vision Care Inc..
6.1.10 SynergEyes Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product Type
Soft Contact Lenses
Hybrid Contact Lenses
Rigid Gas Permeable Contact Lenses
Other Product Types
By Usage
Corrective Contact Lenses
Therapeutic Contact Lenses
Cosmetic Contact Lenses
Prosthetic Contact Lenses
By Modality
Conventional
Disposable
Daily
Monthly
Other Disposable Modalities
By Design
Spherical
Toric
Multifocal
Other Designs
By Distribution Channel
Spectacle Stores
Online Store
Other Distribution Channels
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America